- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder (Urothelial, Transitional Cell) Cancer
Total 10553 results
-
Germans Trias i Pujol HospitalFundació Institut Germans Trias i Pujol; Spanish Clinical Research Network... and other collaboratorsCompletedUrothelial CarcinomaSpain
-
University of Michigan Rogel Cancer CenterTerminatedUrothelial CarcinomaUnited States
-
Peking University Cancer Hospital & InstituteUnknown
-
Genentech, Inc.TerminatedUrothelial CarcinomaKorea, Republic of, United States, Canada, United Kingdom, Belgium
-
Hoosier Cancer Research NetworkNovartis PharmaceuticalsWithdrawnUrothelial Carcinoma
-
Asan Medical CenterCompletedUrothelial CarcinomaKorea, Republic of
-
National Taiwan University HospitalUnknown
-
University of Michigan Rogel Cancer CenterNot yet recruitingUrothelial CarcinomaUnited States
-
Peking University First HospitalRecruiting
-
Peking University Cancer Hospital & InstituteRecruiting
-
Abbisko Therapeutics Co, LtdRecruitingUrothelial CarcinomaChina
-
BeiGeneRecruiting
-
Lee's Pharmaceutical LimitedRecruiting
-
Weill Medical College of Cornell UniversityNeoTX Therapeutics Ltd.WithdrawnUrothelial CarcinomaUnited States
-
University of FloridaCompletedUrothelial CarcinomaUnited States
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingUrothelial CarcinomaNetherlands
-
Case Comprehensive Cancer CenterCompletedUrothelial CarcinomaUnited States
-
4D pharma plcWithdrawnUrothelial CarcinomaUnited States
-
Arjun Balar, MDHoosier Cancer Research Network; Roche-GenentechTerminatedUrothelial CarcinomaUnited States
-
BayerCompletedCarcinoma, Transitional CellUnited States, Spain, Hungary, China, Belgium, Korea, Republic of, Taiwan, Australia, Singapore, Canada, Japan, Sweden, Russian Federation, Germany, Italy, Israel, Ireland, France, Austria, Denmark, Portugal, Switzerland, Czechia, Slo... and more
-
Sohag UniversityCompleted
-
University of Turin, ItalyTesaro, Inc.Completed
-
Samsung Medical CenterActive, not recruitingUrothelial CarcinomaKorea, Republic of
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedUrothelial CarcinomaFrance
-
Hoffmann-La RocheTerminated
-
Mirati Therapeutics Inc.CompletedUrothelial CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedStage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Bladder Carcinoma | Bladder Adenocarcinoma | Bladder Squamous Cell Carcinoma | Bladder Urothelial Carcinoma | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Indiana UniversityTerminatedProstate Cancer | Urothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedMetastatic Urothelial CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Bladder Carcinoma | Recurrent Prostate Carcinoma | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Metastatic Renal Pelvis and Ureter Urothelial Carcinoma | Localized... and other conditionsUnited States
-
Merck Sharp & Dohme LLCCompletedUrothelial Carcinoma Associated 1 RNA, Human
-
G1 Therapeutics, Inc.TerminatedBladder Cancer | Urothelial Carcinoma | Chemotherapy-induced Neutropenia | Myelosuppression Adult | Metastatic Bladder CancerHungary, Spain, United States, France, Georgia
-
RenJi HospitalCompletedNeoadjuvant Immunotherapy of Cisplatin-ineligible High Risk Upper Urinary Tract Urothelial CarcinomaChina
-
University Health Network, TorontoNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder CancerUnited States
-
Gritstone bio, Inc.Bristol-Myers SquibbCompletedColorectal Cancer | Non Small Cell Lung Cancer | Gastroesophageal Adenocarcinoma | Urothelial CarcinomaUnited States, Australia
-
Medical University of South CarolinaTerminated
-
Fox Chase Cancer CenterTemple UniversityActive, not recruitingUrothelial CarcinomaUnited States
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
National Cancer Institute (NCI)CompletedKidney Neoplasms | Urinary Bladder Neoplasms | Urothelial Carcinoma | Urethral NeoplasmsUnited States
-
RemeGen Co., Ltd.RecruitingUrothelial Carcinoma | HER2-expressingChina
-
Shanxi Province Cancer HospitalCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruiting
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingUrothelial CarcinomaUnited States
-
Centre Hospitalier Universitaire de NīmesInstitut Bergonié; Institut de cancérologie Strasbourg Europe; Centre Antoine... and other collaboratorsRecruiting
-
Changhai HospitalRenJi Hospital; West China Hospital; Tongji Hospital; Qilu Hospital of Shandong... and other collaboratorsRecruitingUrothelial CarcinomaChina
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Poland, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus
-
AstraZenecaCompletedUrothelial CarcinomaUnited States
-
Chang Gung Memorial HospitalActive, not recruitingUrothelial CarcinomaTaiwan